Nanosphere to Present at UBS Global Healthcare Conference
(firmenpresse) - NORTHBROOK, IL -- (Marketwired) -- 05/15/13 -- Nanosphere, Inc., (NASDAQ: NSPH), a leader in the development and commercialization of advanced molecular diagnostics systems, today announced that an overview of the company's business and commercial strategy will be given by Nanosphere's President and Chief Executive Officer Michael McGarrity at the UBS Global Healthcare Conference, being held at the Sheraton New York Hotel in New York City. The Company presentation is on Monday, May 20 at 8:30am Eastern Time.
A live webcast of Nanosphere's presentation will be available at .
Nanosphere develops, manufactures and markets an advanced molecular diagnostics platform, the Verigene® System, for multiplexed infectious disease, genetic, and ultra-sensitive protein testing. This easy-to-use platform offers laboratories a convenient, simple, and cost-effective solution for highly sensitive nucleic acid and protein testing. Nanosphere is based in Northbrook, IL.
For additional information regarding Nanosphere's infectious disease products, please contact Nanosphere at or visit .
Except for historical information, the matters discussed in this press release are "forward-looking statements" and are subject to risks and uncertainties. Actual results could differ materially from these forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, the following: (i) Nanosphere's ability to develop commercially viable products; (ii) Nanosphere's ability to achieve profitability; (iii) Nanosphere's ability to produce and market its products; (iv) Nanosphere's ability to obtain regulatory approval of its products; (v) Nanosphere's ability to protect its intellectual property; (vi) competition and alternative technologies; and (vii) Nanosphere's ability to obtain additional financing to support its operations. Additional risks are discussed in the Company's current filings with the Securities and Exchange Commission. Although the Company believes the expectations reflected in such forward-looking statements are based on reasonable assumptions, it can give no assurance that its expectations will be attained. The forward-looking statements are made as of the date of this press release, and we undertake no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.
Contact:
Nanosphere, Inc.
Roger Moody
847-400-9021
Chief Financial Officer
or
LifeSci Advisors
Michael Rice
646-597-6979
Founding Partner
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 15.05.2013 - 06:00 Uhr
Sprache: Deutsch
News-ID 1227520
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
NORTHBROOK, IL
Phone:
Kategorie:
Medical Devices
Anmerkungen:
Diese Pressemitteilung wurde bisher 217 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Nanosphere to Present at UBS Global Healthcare Conference
"
steht unter der journalistisch-redaktionellen Verantwortung von
Nanosphere (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
